Clinical Microbiology Market New High Growth Revenue Sources

Summary

• Technologies Impacting.
• New High Growth Revenue Sources & Global Market Size.
• Top Market Players & Geographic Overview.

Technologies Impacting-

Technologies impacting Clinical microbiology market

• Polymerase Chain Reaction (PCR)

• Enzyme-Linked Immunosorbent Assay (ELISA)

• Microarraysand 34 more

New High Growth Revenue Sources  & Global market size-

New High Growth Revenue Sources for Clinical microbiology market

• Molecular Quality Controls Market - 0.17BN 10.2%

• Mycoplasma Testing Market - 0.69BN 9.7%

• Laboratory Proficiency Testing Market - 0.85BN 6.6%and 18 more

According to the new market research report Clinical Microbiology Market is estimated to be $3.9 billion in 2020 and projected to reach $5.3 billion by 2025, at a CAGR of 6.5%.

Leading Players & Growth Strategies -

The major players operating in the microbiology testing/clinical microbiology market are bioMérieux SA (France), Danaher Corporation (US), Becton, Dickinson and Company (US), Abbott Laboratories (US), Bio-Rad Laboratories, Inc. (US), F. Hoffmann-La Roche AG (Switzerland), Bruker Corporation (US), Hologic, Inc. (US), QIAGEN N.V. (The Netherlands), Thermo Fisher Scientific Inc. (US), Agilent Technologies, Inc. (US), Merck KGaA (Germany), Shimadzu Corporation (Japan), 3M Company (US), and Neogen Corporation (US), among others.

For More Details, Download PDF Brochure

Geographic Overview -

North America is expected to account for the largest share of the global clinical microbiology market in 2018 due to easy accessibility and high adoption of advanced diagnostic techniques, technological advancements in microbial testing techniques, rising geriatric population, and growing public-private funding to support microbiology-based research in the region.